
ééå±ãå«ã55ã®æªç³åååŠå çŽ ãCOVIDã¯ã¯ãã³ããæ€åºããã
å èšäºã¯ãã¡ããã/Click here to read the original article.
ã¢ã«ãŒã³ãã³ã®ç§åŠè ãã¡ããCOVID-19ã¯ã¯ãã³ã®äž»èŠ6ãã©ã³ãã調æ»ããçµæãæ·»ä»ææžã«èšèŒãããŠããªã55ã®ååŠå çŽ ãç¹å®ããããã®ç ç©¶ã¯ããããŸã§ã®ç ç©¶ãè£ä»ãããã®ã§ãããéææ§ã®ç¢ºä¿ãšãããªã調æ»ãæ±ãã声ã«ç«ãã€ããã
ã¢ã«ãŒã³ãã³ã®ç§åŠè ã°ã«ãŒããããã¡ã€ã¶ãŒãã¢ãããã¢ã¹ãã©ãŒãã«ãã«ã³ã·ããã·ããã¡ãŒã ãã¹ããŒããã¯Vã®COVID-19ã¯ã¯ãã³ã«å«ãŸãããæ·»ä»ææžã«ã¯èšèŒãããŠããªã55çš®é¡ã®ååŠå çŽ ãç¹å®ããã
ååŠå çŽ ã«ã¯ãã¯ãã ããçŽ ãããã±ã«ãã¢ã«ãããŠã ãã³ãã«ããé ãªã©11çš®é¡ã®ééå±ãå«ãŸããŠãããç§åŠè ãã¡ã¯ããããã®ééå±ã¯çºã¬ã³æ§ããããäœãæŽé²ã¬ãã«ã§ãèåšé害ãåŒãèµ·ããããšãç¥ãããŠããå šèº«æ¯æ§ç©è³ªã§ãããšèããŠããã
ãŸããè£œé æ¥ã§ãã䜿ãããéè²ã®éãéå±ã§ããã©ã³ã¿ãã€ãïŒåžåé¡å çŽ ïŒ15çš®é¡ã®ãã¡11çš®é¡ãå«ãŸããŠãããã©ã³ã¿ã³ãã»ãªãŠã ãã¬ããªããŠã ãå«ããããã®ååŠå çŽ ã¯ãééå±ã«æ¯ã¹ãŠäžè¬ã«ã¯ããŸãç¥ãããŠããªãããåŒ·ãæ¯æ§ãæã€ããšãæããã«ãªã£ãŠããã
ãCOVID-19 ã¯ã¯ãã³ããééå±ãã©ã³ã¿ãã€ããå«ãè€æ°ã®æªç³åã®ææ¯å çŽ ãæ€åºãããããšã¯ã人éã®å¥åº·ã«å¯ŸããŠäºéã®ããããŠå€éã®æžå¿µãæ±ããããã®ã§ãããããããã®ååŠç©è³ªã¯ãåã ã«ç¥çµåŠçãå¿èè¡ç®¡åŠçãå ç«åŠçé害ãåŒãèµ·ããããšãç¥ãããŠããã
ããããã®ååŠç©è³ªã®çžä¹çæ¯æ§ã¯ãèŠå¶åœå±ãã¡ãŒã«ãŒãå ¬è¡šãããç ç©¶ãããããç¯å²ãã¯ããã«è¶ ããŠããããã®ãªã¹ã¯ãæªåãããå¯èœæ§ããããŸãã
ãã®ç ç©¶ã¯ãäž»èŠã¡ãŒã«ãŒã®COVID-19ã¯ã¯ãã³ãã€ã¢ã«ãåæããããã«ãç°ãªãåææè¡ãçšããŠ2021幎以éã«å®æœãããäžé£ã®ç ç©¶ãåºç€ãšããŠããããããŸã§ã®ç ç©¶ã§ããã¯ã¯ãã³ã®ã©ãã«ã«èšèŒãããŠããªãååŠå çŽ ãçžåœæ°ç¢ºèªãããŠããã
ç ç©¶åªåã«ã¯ãæ ã¢ã«ãã»ãã«ã¯ãã«ãç çåŠè ãå«ããã€ãã®ã¯ãŒãã³ã°ã°ã«ãŒãããã€ãæ¿åºã«æåºãã2022幎ã®ç ç©¶ãã€ã®ãªã¹ã®ç§åŠè ã«ãã2021幎ã®ç ç©¶ãã«ããã®ãããšã«ã»ãã¬ã»å士ã«ãã2022幎ã®ç ç©¶ããããŠã²ã¢ããã»ãã®ãå士ã«ãã2023幎ã®ã«ãŒããã¢ã®ç ç©¶ãªã©ãå«ãŸããã
ãããã®äžççãªç ç©¶ãéããŠã2023幎æ«ãŸã§ã«ç ç©¶è ãã¡ã¯COVID-19ã¯ã¯ãã³ã®åŠæ¹äžã«24ã®æªç³åã®ååŠå çŽ ãç¹å®ããã
ã¢ã«ãŒã³ãã³ã®ç ç©¶ã®å ±èè ã§ãããã«ã»ã©ã»ãµã³ãŽãªã³å士ã¯ããååœã®èŠå¶åœå±ã«ããçç©åŠç補å€ã®å質管çã«ã¯å€§ããªéãããããã
ããã®ç¶æ³ã¯ãæå 端ã®ãã€ãªãã¯ãããžãŒéçºã«ãããŠèгå¯ãããæ¥éãªé²æ©ãèæ ®ãããšãããã«ç·æ¥ãã€æžå¿µãã¹ããã®ã§ããããã®è€éãããã«ããããã®æ²»çæ³ãéžæããå人ã®å®å šæ§ã確ä¿ããããã«ããã培åºããæ³èŠå¶ã®æ çµã¿ãå¿ èŠãªã®ã§ã "ãšSangorrÃnæ°ã¯è¿°ã¹ãã
CDCãã¯ã¯ãã³è³Šåœ¢å€æ å ±ããã»ãšãã©èŠã€ããããšãäžå¯èœãã«
ã¢ã«ãŒã³ãã³ã§ã®ç ç©¶ã§ã¯ãç ç©¶è ãã¡ã¯ãæªç³åæåã«é¢ãããããŸã§ã®ç¥èŠãè£ä»ãããããã®ç ç©¶ã§åå®ãããªãã£ãæåãæ€åºã»æž¬å®ããããšãç®çãšããã
ç ç©¶ããŒã ã¯ãã³ã«ããåœç«å€§åŠã®ç 究宀ã§ãCOVID-19ã¯ã¯ãã³6éæã®ç°ãªããããã®ãã€ã¢ã«13æ¬ãåæãããé«æåºŠåææè¡ã§ããèªå°çµåãã©ãºã質éåææ³ã䜿çšããã
ç ç©¶è ãã¡ã¯ãåã¯ã¯ãã³ã®å°ãªããšã2ã€ã®ãã€ã¢ã«ãåæããããã ããäžåœè£œã®ãŠã€ã«ã¹ãã¯ã¿ãŒã¯ã¯ãã³ã§ããCanSinoã«ã€ããŠã¯ã1ã€ã®ãã€ã¢ã«ããåæããªãã£ãã
圌ãã®è«æã«ã¯ãã¡ãŒã«ãŒãç³åããCOVID-19ã¯ã¯ãã³æåã®é·ããªã¹ããå«ãŸããŠãããæåã¯ã¯ã¯ãã³ã¡ãŒã«ãŒã«ãã£ãŠç°ãªããç ç©¶è ãã¡ã¯æ å ±å ¬éè«æ±ã«ãã£ãŠãªã¹ããå ¥æããã
ã¹ããŒããã¯Vãšã·ããã¡ãŒã ãé€ããŠãã¡ãŒã«ãŒã¯ã¯ã¯ãã³ã«å«ãŸãã賊圢å€ã®éãç³åããŠããªãã
ã¯ã¯ãã³ã«ã¯ãã°ãã°è³Šåœ¢å€ïŒé²è å€ãã¢ãžã¥ãã³ããå®å®å€ããã®ä»ã®ç®çã§äœ¿çšãããæ·»å ç©ïŒãå«ãŸããŠãããç±³åœçŸç äºé²ç®¡çã»ã³ã¿ãŒïŒCDCïŒã«ããã°ãã¯ã¯ãã³ã®è£œé ã«äœ¿çšãããããæçµè£œåã®å 容ç©ã«ã¯èšèŒãããŠããªãç©è³ªã¯ãæ·»ä»ææžã®ã©ããã«èšèŒãããã¹ãã§ããã
ãªããªãã賊圢å€ã«ã¯ã¢ã¬ã«ã²ã³ããã®ä»ã® ãé ããå±éºæ§ããå«ãŸããŠããå¯èœæ§ãããããã§ããã
OpenVAERSã«ããã°ãCDCã¯äžè¬ã«å ¥æå¯èœãªã¯ã¯ãã³è³Šåœ¢å€æ å ±ã ãã»ãšãã©äžå¯èœ ãã«ããŠãããOpenVAERSã¯ãã¯ã¯ãã³ã®çš®é¡å¥ããã³ã¯ã¯ãã³å¥ã®è³Šåœ¢å€ã®å æ¬çãªãªã¹ããæäŸããŠããŸãã
ããããªãããOpenVAERSã®ãŠã§ããµã€ãã§ã¯ãã¯ã¯ãã³ãã€ã¢ã«ãç¬èªã«æ€æ»ããçµæãä»åã®ç ç©¶ã§æããã«ãªã£ããã㪠ãã¡ãŒã«ãŒãå ¬è¡šããŠãã以äžã®æ±æç©è³ª ããæ€åºãããããšãææããŠããã
ç ç©¶è ãã¡ã¯ãååŠåæã®çµæãã¯ã¯ãã³ã«ãã£ãŠããŸãæ€æ»ãããã€ã¢ã«ã«ãã£ãŠãç°ãªãããšãçºèŠãããããã€ãã®ã±ãŒã¹ã§ã¯ããã€ã¢ã«ã¯ç°ãªãæ¥ä»ã§ç¹°ãè¿ãæ€æ»ããããããã«ç°ãªãçµæãåºãã
ã¢ã¹ãã©ãŒãã«ã®ã¯ã¯ãã³ã®ãããããã§ã¯ã15çš®é¡ã®ååŠå çŽ ãæ€åºããããã®ãã¡14çš®é¡ã¯æªç³åã§ãã£ããããäžæ¹ã®ãããã§ã¯21ã®å çŽ ãæ€åºããããã¡20ã¯æªç³åã§ãã£ãããã£ã³ã·ãã®ãã€ã¢ã«ã§ã¯22ã®å çŽ ãæ€åºããããã¡20ã¯æªç³åã§ãã£ãã
ãã¡ã€ã¶ãŒã®3ã€ã®ãã€ã¢ã«ã«ã¯ãããã19ã16ã21-23ã®æªç³åæåãå«ãŸããŠãããModernaã®ãã€ã¢ã«ã«ã¯21çš®é¡ã16-29çš®é¡ã®æªç³åæåãå«ãŸããŠãããã·ããã¡ãŒã ã®ãã€ã¢ã«ã«ã¯17-23ã®æªç³åå çŽ ããã¹ããŒããã¯Vã«ã¯19-25ã®æªæ€åºå çŽ ãå«ãŸããŠããã
æ€æ»ããã¯ã¯ãã³ã®82ïŒ ã«æªç³åã®ãçŽ ãå«ãŸããŠãã
å šäœãšããŠãç ç©¶è ã¯åæãã17ã®ãµã³ãã«ã§55çš®é¡ã®æªç³åå çŽ ãç¹å®ããã
æ€åºãããééå±ã¯ãã¹ãŠã人éã®å¥åº·ã«æå®³ãªåœ±é¿ãäžãããã®ã§ãã£ããééå±ã®æ€åºé »åºŠã¯ç°ãªããããã®å€ãã¯è€æ°ã®ãµã³ãã«ã«ãŸããã£ãŠæ€åºãããã
ãããŠçŽ ãã«ã«ã·ãŠã ããã¿ã³ãã¢ã«ãããŠã ããçŽ ãããã±ã«ãã¯ãã ãé ãã¬ãªãŠã ãã¹ããã³ããŠã ãããªããã¢ãªããã³ãããªãŠã ãããããŠã ã®ãããªæªç³åã®ååŠå çŽ ããCOVID-19ã¯ã¯ãã³ã®ãã¹ãŠã®éæã«å ±éããŠååšããããšç ç©¶è ãã¡ã¯æžããŠããã
é節ãªçãç®èç ã®ãªã¹ã¯ãé«ããã¯ãã ã ãçŽ ã®ãããªä»ã®å çŽ ã¯ããããããµã³ãã«ã®100ïŒ ãš82ïŒ ã«æªç³åå çŽ ãšããŠå«ãŸããŠããããŸããèèã«ãã¡ãŒãžãäžããèºå¡æ çã®åå ãšãªãã©ã³ã¿ãã€ãã®ã»ãªãŠã ã76ïŒ ã®ãµã³ãã«ããæ€åºãããã
ãããã®ååŠå çŽ ã¯ãä»åã®ç ç©¶ãšéå»ã®ç ç©¶ãåããã62çš®é¡ã®æªç³åååŠå çŽ ã®ã»ãã®äžäŸã«éããªãããšç ç©¶è ãã¡ã¯æžããŠããã
ç ç©¶è ãã¯ããçºèŠãããå çŽ ã®ç¹ç°ãªç¹åŸŽãšãšãã«ããã¹ãŠã®ãã©ã³ãã«ããã倿§æ§ãšé¡èãªååšããèæ ®ãããšãä»åã®çºèŠãæ±æãå¶çºçãªæ··å ¥ã«ãããã®ã§ããå¯èœæ§ã¯äœããšçµè«ã¥ããŠããã
ååœæ¿åºããããã®è£œåã調æ»ããããšããæãç·æ¥ãã§ãã
ç ç©¶è ãã¯ããã®æ¢çŽ¢çç ç©¶ã¯ãµã³ãã«æ°ãå°ãªãããéçããããšããããå€ãã®ãµã³ãã«ãçšããããåºç¯ãªåæãæ±ããã圌ãã¯ãããåºç¯ãªåæã«ãã£ãŠã圌ããç¹å®ããåŸåã確èªã§ããã ãããšç€ºåããã
ãµã³ãŽãªã³ã¯ãããã¯æ¿åºç ç©¶è ã®ä»äºã§ããã¹ãã ãšè¿°ã¹ãã
ãäžçäžã®æ¿åºãããã¡ãŒãã³ããžã©ã³ã¹ãéããŠç¹å®ãããå質ã«é¢ããèŠæ ã«å¯Ÿå¿ããããã«äžè¬çã«è¡ãããŠããããã«ããããã®è£œåã«é¢é£ãã調æ»ã宿œããããšãäœãããæ¥åã§ãããšåœŒå¥³ã¯è¿°ã¹ãã
æ£çŸ©ãæ±ãã人ã ã¯ãäžçä¿å¥æ©é¢ïŒWHOïŒã補è¬äŒç€Ÿãååœæ¿åºã«å¯Ÿãããäžççãªæ»äº¡çã®äžæãèšé²ãããå¯äœçšããããŠãããã®è£œåãå ç«ãæäŸããæå³ã§éçºããããã®ã§ã¯ãªãããšãæç¢ºã«èšŒæãããããšãèžãŸããäºæ ã®æ·±å»ãã«å¿ããŠãç·æ¥ã®è¡åãåãããæ±ããªããã°ãªããªãããšåœŒå¥³ã¯ä»ãå ããã
èè ãã¯ãCOVID-19ã¯ã¯ãã³ã«é¢é£ããæ»äº¡ãå«ãéç¯€ãªæå®³äºè±¡ãäžççã«é«çã«çºçããŠããããšã匷調ãããèè ãã¯ãæå®³äºè±¡ãšæ»äº¡ã¯ãå®è³ªçã«éå°è©äŸ¡ãããŠããå¯èœæ§ãé«ããåå®ãããæ¯çŽ ã«é¢é£ããŠããå¯èœæ§ã瀺åããã
ã©ã€ãªã³ãºïŒã¯ã€ã©ãŒæ°ã¯ãŸããå ¬è¡è¡çãå®ãããã®èŠå¶æªçœ®ãæ±ããã
ãèŠå¶æ©é¢ã¯ããããã®ã¯ã¯ãã³ã®äœ¿çšãäžæ¢ãããããã®æ¯çŽ ãã©ã®ããã«ããŠèŠèœãšããããã培åºçã«èª¿æ»ããå šæåãéææ§ããã£ãŠç³åããå ¬è¡ã«æ£åœã«ãã€ååã«èŠåãããããçŽã¡ã«è¡åãèµ·ãããªããã°ãªããªãã
ãåœæ°ã®å¥åº·ã¯ããã®ãããªé倧ãªäžç¢ºå®æ§ã«çŽé¢ããŠããã¯ãè³ããããšã¯ã§ããªãã